Abstract
Platelets are capable of synthesizing complex lipids from acetate, glycerol, and from preformed fatty acids. In addition alterations in lipid metabolism and in the orientation of lipids in membranes are integral to normal function. Furthermore, abnormalities of lipid metabolism and composition have been associated with altered platelet function. Therefore, platelets are attractive for the study of the role of lipids in cellular function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennett, J. S., Shattil, S. J., Cooper, R. A., and Colman, R. W. 1974. Platelet hypersensitivity in familial hyperbetalipoproteinemia: The role of platelet lipid composition. Blood 44:918.
Bjerve, K. S. 1973. The Ca2+-dependent biosynthesis of lecithin, phosphatidylethanolamine, and phosphatidylserine in rat liver subcellular particles. Biochem. Biophys. Acta 296:549–562.
Call, F. L., and Williams, W. J. 1970. Biosynthesis of cytidine diphosphate diglyceride by human platelets.J. Clin. Invest. 49:392–397.
Call, F. L., and Rubert, M. 1975. Synthesis of ethanolamine phosphoglycerides by human platelets. J. Lipid Res. 16:352–359.
Carvalho, A. C. A., Colman, R. W., and Lees, R. S. 1974. Platelet function in hyperlipoproteinemia. New Eng. J. Med. 290:434–438.
Cohen, P., Derksen, A., and van den Bosch, H. 1970. Pathways of fatty acid metabolism in human platelets. J. Clin. Invest. 49:128–139.
Cohen, P., Broekman, M. J., Verkley, A., Lisman, W. W., and Derksen, A. 1971. Quantification of human platelet inositides and the influence of ionic environment on their incorporation of orthophosphate-32P. J. Clin. Invest. 50:762–772.
Derksen, A., and Cohen, P. 1973. Extensive incorporation of (2-14C) mevalonic acid into cholesterol precursors by human platelets in vitro. J. Biol. Chem. 248:7396–7403.
Deykin, D. 1971. The sub-cellular distribution of platelet lipids labeled by acetate 1-14C. J. Lipid Res. 12:9–11.
Deykin, D. 1973. Altered lipid metabolism after primary aggregation. J. Clin. Invest. 52:483–492.
Deykin, D., and Desser, R. K. 1968. The incorporation of acetate and palmitate into lipids by human platelets.J. Clin. Invest. 47:1590–1602.
Deykin, D., and Snyder, D. 1973. The effect of epinephrine on platelet lipid metabolism J. Lab. Clin. Med. 82:554–559.
Eisbach, P., Pettis, P., and Marcus, A. J. 1971. Lysolecithin metabolism by human platelets. Blood 37:675–683.
Hamberg, M., and Samuelsson, B. 1974. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA 71:3400–3404.
Hamberg, M., Svensson, J., Wykabayaski, T., and Samuelsson, B. 1974a. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 71:345–349.
Hamberg, M., Svensson, J., and Samuelsson, B. 1974b. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc. Natl. Acad. Sci. USA 71:3824–3828.
Hamberg, M., Svensson, J., and Samuelsson, B. 1975. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 72:2994–2998.
Hennes, A. R., Awai, K., Hamerstrand, K., and Duboff, G. 1966. Carbon-14 in carboxyl carbon of fatty acids formed by platelets from normal and diabetic subjects. Nature 210:839–841.
Hoak, J. C., Spector, A. A., Fry, G. L., and Barnes, B. C. 1972. Localization of free fatty acids taken up by human platelets. Blood 40:16–22.
Hokin, L. E. 1969. Functional activity in glands and synaptic tissue and the turnover of phosphatidylinositol. Ann. N. Y. Acad. Sci. 165:695.
Hutton, R. A., and Deykin, D. 1973. The effect of ADP on phosphatidylinositol synthesis in normal and storage pool deficient human platelets. Proc. 16th Annual Meeting, Am. Soc. Hematol.: p. 116, Abstr. No. 238.
Kanfer, J. N. 1972. Base exchange reactions of the phosphoinositides in rat brain particles.J. Lipid Res. 13:468–476.
Kloeze, J. 1969. Relationship between chemical structure and platelet aggregation activity of prostaglandins. Biochem. Biophys. Acta 187:285–292.
Krivit, W., and Hammarstron, S. 1972. Identification and quantitation of free ceramides in human platelets. J. Lipid Res. 13:525–530.
Lewis, N., and Majerus, P. W. 1969. Lipid metabolism in human platelets II. De Novo phospholipid synthesis and the effect of thrombin on the pattern of synthesis. J. Clin. Invest. 48:2114–2123.
Lloyd, J. V., and Mustard, J. F. 1974. Changes in 32P content of phosphatidic acid and the phosphoinositides of rabbit platelets during aggregation induced by collagen or thrombin. Br. J. Haematol. 16:243–253.
Lloyd, J. F., Nishizawa, E. E., and Mustard, J. F. 1973. Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di-, and triphosphati-dylinositol. Br. J. Haematol. 25:77–99.
Lucas, C. T., Call, F. L., and Williams, W. J. 1970. The biosynthesis of phosphatidylinositol in human platelets. J. Clin. Invest. 49:1949–1955.
Majerus, P. W., Smith, M. B., and Clamon, G. H. 1969. Lipid metabolism in human platelets I. Evidence for a complete fatty acid synthesizing system.J. Clin. Invest. 48:156–164.
Malmsten, C., Hamberg, M., Svensson, J., and Samuelsson B. 1975. Physiological role of an endoperoxide in human platelets: Hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc. Natl. Acad. Sci. USA 72:1446–1450.
Marcus, A. J., Ullman, H. L., and Safier, L. B. 1969. Lipid composition of subcellular particles of human blood platelets. J. Lipid Res. 10:108–114.
Marcus, A. J., Ullman, H. L., and Safier, L. B. 1972. Studies on human platelet gangliosides.J. Clin. Invest. 51:2602–2612.
Marcus, A. J., Safier, L. B., and Ullman, H. L. 1975. Interactions between 5-hydroxytryptamine and platelet lipid fractions, pp. 309–326. In Biochemistry and Pharmacology of Platelets. CIBA Foundation Symposium 35 (New Series) American-Elsevier, N.Y.
Marks, P. A., Gellhorn, A., and Kidson, C. 1960. Lipid synthesis in human leukocytes, platelets, and erythrocytes. J. Biol. Chem. 235:2579–2583.
Okuma, M., Yamashita, S., and Numa S. 1973. Enzymic studies on phosphatidic acid synthesis in human platelets. Blood 41:379–389.
Porcellati, G., Arienti, G., Pirotta, M., and Giorgini, D. 1971. Base-exchange reactions for synthesis of phospholipids in nervous tissue: The incorporation of serine and ethanolamine into the phospholipids of isolated brain microsomes. J. Neurochem. 18:1395–1417.
Russell, F. A., and Deykin, D. 1976. The effect of thrombin on the uptake and transformation of arachidonic acid by human platelets. Am. J. Hematol. 1:59–70.
Saftit, W., Weiss, H. J., and Phillips, G. 1972. The phospholipid and fatty acid composition of platelets in patients with primary defects of platelet function. Lipids 7:60–67.
Salzman, E. W., Stead, N., and Deykin, D. 1973. Interrelations of platelet prostaglandin synthesis and cyclic AMP metabolism. IVth International Congress on Thrombosis and Hemostasis, Vienna, p. 78, Abstr. No. 46.
Schick, P. K., and Yu, B. P. 1974. The role of platelet membrane phospholipids in the platelet release reaction. J. Clin. Invest. 54:1032–1039.
Shattil, S. J., Anaya-Galindo, R., Bennett, J., Colman, R. W., and Cooper, R. A. 1975. Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55:636–643.
Shio, H., and Ramwell, P. W. 1972. Effect of prostaglandin E2 and aspirin on the secondary aggregation of human platelets. Nat. New Biol. 236:45–46.
Smith, J. B., and Willis, A. L. 1971. Aspirin selectively inhibits prostaglandin production in human platelets. Nat. New Biol. 231:235–237.
Smith, J. B., Ingerman, C., Kocsis, J. J., and Silver, M. J. 1974. Formation of an intermediate in prostaglandin synthesis and its association with the platelet release reaction. J. Clin. Invest. 53:1468–1472.
Snyder, P. D., Desnick, R. S., and Krivit, W. 1972. The glycosphingolipids and glycosyl hydrolases of human blood platelets. Biochem. Biophys. Res. Commun. 46:1857–1865.
Spector, A. A., Hoak, J. D., Warner, E. D., and Fry, G. L. 1970. Utilization of long-chain free fatty acids by human platelets. J. Clin. Invest. 49:1489–1496.
Turner, S. R., Tainer, J. A., and Lynn, W. S. 1975. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase of platelets. Nature 257:680–681.
Willis, A. L. 1974a. En enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science 183:325–327.
Willis, A. L. 1974b. Isolation of a chemical trigger for thrombosis. Prostaglandins 5:1–25.
Willis, A. L., and Weiss, H. J. 1973. A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins 4:783–794.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Deykin, D. (1977). Platelet Lipids. In: Snyder, F. (eds) Lipid Metabolism in Mammals. Monographs in Lipid Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2832-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2832-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2834-6
Online ISBN: 978-1-4684-2832-2
eBook Packages: Springer Book Archive